LXRX Overview
Upcoming Projects (LXRX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (LXRX)
-
2025 Q1 #3 Speaking with a Cardiologist who has experience treating heart failure patients to discuss the standard of care and the use of Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Jan 17, 2025 at 09:00 AM EST -
2025 Q1 #2 Speaking with a Cardiologist who has experience treating heart failure patients to discuss the standard of care and the use of Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Jan 07, 2025 at 10:00 AM EST -
2025 Q1 #1 Speaking with a Cardiologist who has experience treating heart failure patients to discuss the standard of care and the use of Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Jan 06, 2025 at 04:00 PM EST -
Q4 #3 Speaking with a Cardiologist who has experience treating heart failure patients to discuss the standard of care and the use of Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Nov 13, 2024 at 08:30 AM EST -
Q4 #2 Speaking with a Cardiologist who has experience treating heart failure patients to discuss the standard of care and the use of Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Oct 08, 2024 at 12:00 PM EDT -
Q4 #1 Speaking with a Cardiologist who has experience treating heart failure patients to discuss the standard of care and the use of Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Oct 04, 2024 at 10:00 AM EDT -
A Third Look: Speaking with a Cardiologist who has experience treating heart failure patients to discuss the standard of care and the use of Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Aug 20, 2024 at 01:00 PM EDT -
A Second Look: Speaking with a Cardiologist who has experience treating heart failure patients to discuss the standard of care and the use of Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Aug 07, 2024 at 05:00 PM EDT -
Speaking with a Cardiologist who has experience treating heart failure patients to discuss the standard of care and the use of Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Aug 06, 2024 at 01:30 PM EDT -
A Third Look: Discussing the standard of care and potential of Inpefa (sotagliflozin), for treating patients with heart failure with current prescribers of the medication
Ticker: LXRX
Executed On: Feb 14, 2024 at 12:00 PM EST -
A Second Look: Discussing the standard of care and potential of Inpefa (sotagliflozin), for treating patients with heart failure with current prescribers of the medication
Ticker: LXRX
Executed On: Jan 19, 2024 at 08:30 AM EST -
Discussing the standard of care and potential of Inpefa (sotagliflozin), for treating patients with heart failure with current prescribers of the medication
Ticker: LXRX
Executed On: Dec 13, 2023 at 07:30 AM EST -
A Third Look: Delving into the data from the SCORED and SOLOIST-WHF phase 3 clinical trials on Lexicon's recently approved dual SGLT1 and SGLT2 inhibitor Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Jul 13, 2023 at 12:00 PM EDT -
A Second Look: Delving into the data from the SCORED and SOLOIST-WHF phase 3 clinical trials on Lexicon's recently approved dual SGLT1 and SGLT2 inhibitor Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Jun 22, 2023 at 07:00 PM EDT -
Delving into the data from the SCORED and SOLOIST-WHF phase 3 clinical trials on Lexicon's recently approved dual SGLT1 and SGLT2 inhibitor Inpefa (sotagliflozin).
Ticker: LXRX
Executed On: Jun 07, 2023 at 05:15 PM EDT
Expired Projects (LXRX)
Upcoming & Overdue Catalysts (LXRX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (LXRX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
